Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in China

Abstract

Hepatitis B vaccine has been successfully integrated into routine infant immunization in China, now reaching most infants within 24 h after birth, and the prevalence of hepatitis B surface antigen has been greatly reduced among children born after 1992.